{"id":625979,"date":"2022-11-16T19:24:01","date_gmt":"2022-11-16T19:24:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=625979"},"modified":"2022-11-16T19:24:01","modified_gmt":"2022-11-16T19:24:01","slug":"bone-metastasis-in-solid-tumors-market-to-grow-substantially-during-the-forecast-period-202232-delveinsight-key-companies-actuate-therapeutics-exelixis-bayer-amgen","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/bone-metastasis-in-solid-tumors-market-to-grow-substantially-during-the-forecast-period-202232-delveinsight-key-companies-actuate-therapeutics-exelixis-bayer-amgen_625979.html","title":{"rendered":"Bone Metastasis in Solid Tumors Market to Grow Substantially During the Forecast Period (2022-32) – DelveInsight | Key Companies – Actuate Therapeutics, Exelixis, Bayer, Amgen"},"content":{"rendered":"
\n
\"Bone<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
As per DelveInsight, the Bone Metastasis In Solid Tumors market size is anticipated to increase in the coming years owing to the rising cases of bone metastasis in solid tumors in the 7MM, the growth in healthcare spending, and the launch of new therapies for bone metastasis treatment in the market.<\/div>\n

DelveInsight’s “Bone Metastasis in Solid Tumors Market Insights, Epidemiology, and Market Forecast 2032<\/strong>” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Bone Metastasis in Solid Tumors market size, share, and trends in the United States, EU5 (i.e., the UK, Italy, Spain, Germany, France), and Japan.<\/p>\n

The Bone Metastasis in Solid Tumors market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

\"Bone<\/p>\n

Bone Metastasis in Solid Tumors: An Overview<\/strong><\/p>\n

Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types of cancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to the bone, including breast cancer and prostate cancer.  The development of bone metastases can be considered in several stages: colonization, quiescence, and progression, either locally leading to overt metastasis in bone or dissemination to another site.<\/p>\n

Bone metastasis is common and is one of the leading causes of complications in the natural history of cancer. The consequences of bone metastasis may compromise the quality of life, limit day-to-day activities, threaten life expectancy, and increase medical intervention and expenses. The complications of bone metastases, usually referred to as skeletal-related events (SREs) include pain, hypercalcemia, bone fractures, and nerve compression that may require radiation therapy (RT) or surgery.<\/em><\/p>\n

Bone Metastasis in Solid Tumors Market Key Facts<\/strong><\/p>\n